Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

NCT00526305

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Hospital General de Alicante Alicante, Spain

Hospital Ntra. Sra. Sonsoles Ávila, Avila, Spain

Hospital Clínic Barcelona, Spain

Hospital del Mar Barcelona, Spain

View all 50 locations

View Trial Details

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

NCT00182650

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

NCT00229203

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Jerome Lipper Multiple Myeloma Center - Dept of Medical Oncology - Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion

NCT00292760

Conditions: Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

NCT00466258

Conditions: Blood-Borne Infections, Communicable Diseases, Diffuse Large B Cell Lymphoma, +22 more
Locations: H. Son Llatzer Palma de Mallorca, Balearic Islands, Spain

Germans Trias i Pujol Badalona, Barcelona, Spain

H. Clínic i Provincial, Barcelona Barcelona, Spain

H. Vall d'Hebron, Barcelona Barcelona, Spain

View all 15 locations

View Trial Details

Completed

Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy

NCT01018758

Conditions: Chemotherapy-induced Nausea and Vomiting, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Gruppo Italiano Studio Linfomi Modena, Italy

View Trial Details

Completed

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

NCT00195533

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: A Coruña, Spain

Alcalá de Henares, Spain

Alzira, Spain

Barcelona, Spain

View Trial Details

Completed

Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

NCT00608452

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +41 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

NCT00021749

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations: Long Island Jewish Medical Center New Hyde Park, New York, United States

MD Anderson Cancer Center Houston, Texas, United States

San Antonio Cancer Institute San Antonio, Texas, United States

View Trial Details

Completed

Mantle Irradiation for Hodgkin's Disease

NCT00165269

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions